Could Vertex Have a Cure for Type 1 Diabetes on the Way?

Vertex Pharmaceuticals (NASDAQ: VRTX) reported positive results in October from an early stage clinical study evaluating VX-880 in treating type 1 diabetes. The New York Times recently published an article about these results, suggesting that Vertex could even have a cure for type 1 diabetes. 

In this Motley Fool Live video recorded on Dec. 1, 2021, Motley Fool contributors Keith Speights and Brian Orelli answer a viewer's question about Vertex's experimental diabetes therapy.

Continue reading

Source Fool.com